Brown Brothers Harriman & Co’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.6K Hold
42
﹤0.01% 1296
2026
Q1
$15.9K Hold
42
﹤0.01% 1264
2025
Q4
$18K Sell
42
-61
-59% -$26.6K ﹤0.01% 1234
2025
Q3
$46.1K Buy
103
+6
+6% +$2.72K ﹤0.01% 1017
2025
Q2
$47.2K Sell
97
-12
-11% -$6.84K ﹤0.01% 946
2025
Q1
$67.1K Buy
109
+21
+24% +$11.9K ﹤0.01% 782
2024
Q4
$46.6K Buy
88
+76
+633% +$42.8K ﹤0.01% 895
2024
Q3
$7.21K Buy
+12
New +$6.8K ﹤0.01% 1098
2023
Q2
Sell
-44
Closed -$23.7K 1232
2023
Q1
$23.7K Hold
44
﹤0.01% 860
2022
Q4
$22.5K Hold
44
﹤0.01% 856
2022
Q3
$19K Hold
44
﹤0.01% 982
2022
Q2
$21K Hold
44
﹤0.01% 869
2022
Q1
$22K Sell
44
-29
-40% -$13.9K ﹤0.01% 907
2021
Q4
$39K Buy
73
+44
+152% +$21.1K ﹤0.01% 744
2021
Q3
$13K Buy
+29
New +$13.7K ﹤0.01% 872
2018
Q1
Sell
-25
Closed -$6K 854
2017
Q4
$6K Buy
+25
New +$5.68K ﹤0.01% 813

Other funds holding CHE

Brown Brothers Harriman & Co's CHE Position: Q2 2026 in Review

Brown Brothers Harriman & Co held its Chemed (CHE) position steady in Q2 2026 at 42 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1296.

Brown Brothers Harriman & Co first reported a position in CHE in Q4 2017 and has held it in 16 quarters since. The position peaked at $67.1K in Q1 2025. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Brown Brothers Harriman & Co held 42 shares of Chemed worth $19.6K as of Q2 2026.
  • Brown Brothers Harriman & Co left its Chemed share count unchanged in Q2 2026.
  • Chemed made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1296 holding.
  • Brown Brothers Harriman & Co first reported a position in Chemed in Q4 2017 and has held it in 16 quarters since.
  • Brown Brothers Harriman & Co's Chemed position peaked at $67.1K in Q1 2025.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.